The CINSARC signature predicts the clinical outcome in patients with Luminal B breast cancer

CINSARC, a multigene expression signature originally developed in sarcomas, was shown to have prognostic impact in various cancers. We tested the prognostic value for disease-free survival (DFS) of CINSARC in a series of 6035 early-stage invasive primary breast cancers. CINSARC had independent progn...

Descripción completa

Detalles Bibliográficos
Autores principales: Goncalves, Anthony, Finetti, Pascal, Birnbaum, Daniel, Bertucci, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099860/
https://www.ncbi.nlm.nih.gov/pubmed/33953185
http://dx.doi.org/10.1038/s41523-021-00256-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099860/
https://www.ncbi.nlm.nih.gov/pubmed/33953185
http://dx.doi.org/10.1038/s41523-021-00256-2

Ejemplares similares